From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Levomilnacipran may increase bleeding risk, and ginkgo may add mild antiplatelet effects.
Mechanism. Serotonin reuptake inhibition can impair platelet aggregation; ginkgo may independently affect hemostasis.
Recommendation. Use cautiously, particularly with anticoagulants, antiplatelet therapy, frequent NSAIDs, bleeding disorders, or upcoming procedures.
Stack Score
How it moves the number.
Effect on the composite score
If both Ginkgo Biloba and Levomilnacipran are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Allergan USA Inc. FETZIMA US Prescribing Information. 2024.Needs sourceNo link